Larimar Therapeutics Inc (LRMR)

[Wildbilly]

Zafgen down further after hours as complete clinical hold ordered - Zafgen, Inc. (NASDAQ:ZFGN)

Well, there we have it, I'll really be paying attention now.

Following another death in its Phase 3 trial for lead product candidate beloranib, Zafgen (ZFGN -60.6%) says now that its IND application for the drug has been placed on complete clinical hold.

Shares are down another 2.7% after hours following the news, after today's decline steepened from a premarket drop.

The drug had been placed on a partial clinical hold in October, after the first death related to blood clots in the trial.

The order is to suspend all clinical work under the application.

"We remain committed to advancing beloranib as a potential new therapy for this underserved patient population [with Prader-Willi Symdrome]," said CEO Dr. Thomas Hughes.

Previously: Zafgen reports another blood clot-related death in its late-stage study of beloranib in obese patients with Prader-Willi syndrome; shares off 37% premarket (Dec. 02 2015)

http://seekingalpha.com/news/2962446-zafgen-down-further-after-hours-as-complete-clinical-hold-ordered?uprof=44#email_link